RCG
ELV icon

Ruane, Cunniff & Goldfarb’s Elevance Health ELV Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379M Sell
979,598
-408,370
-29% -$151M 5.89% 6
2026
Q1 		$406M Sell
1,387,968
-34,538
-2% -$11.4M 6.74% 6
2025
Q4 		$499M Sell
1,422,506
-25,777
-2% -$8.71M 7.79% 5
2025
Q3 		$468M Buy
1,448,283
+352,628
+32% +$110M 7.75% 5
2025
Q2 		$426M Sell
1,095,655
-27,265
-2% -$11M 7.31% 6
2025
Q1 		$488M Sell
1,122,920
-21,033
-2% -$8.44M 8.87% 3
2024
Q4 		$422M Buy
1,143,953
+139,420
+14% +$58.3M 7.16% 6
2024
Q3 		$522M Sell
1,004,533
-19,538
-2% -$10.4M 8.17% 3
2024
Q2 		$555M Sell
1,024,071
-50,614
-5% -$26.8M 8.65% 3
2024
Q1 		$557M Sell
1,074,685
-46,958
-4% -$23.4M 8.65% 3
2023
Q4 		$529M Sell
1,121,643
-28,578
-2% -$13.2M 8.45% 4
2023
Q3 		$501M Buy
1,150,221
+101,573
+10% +$46.1M 8.31% 3
2023
Q2 		$466M Buy
1,048,648
+241,524
+30% +$111M 7.35% 6
2023
Q1 		$371M Sell
807,124
-19,399
-2% -$9.23M 6.06% 7
2022
Q4 		$424M Sell
826,523
-161,334
-16% -$81.9M 6.62% 5
2022
Q3 		$449M Sell
987,857
-26,130
-3% -$12.5M 6.67% 5
2022
Q2 		$489M Sell
1,013,987
-743,441
-42% -$368M 6.38% 7
2022
Q1 		$863M Sell
1,757,428
-12,612
-0.7% -$5.76M 8.5% 2
2021
Q4 		$820M Sell
1,770,040
-51,373
-3% -$21.6M 7.01% 5
2021
Q3 		$679M Sell
1,821,413
-22,588
-1% -$8.58M 6.1% 6
2021
Q2 		$704M Buy
1,844,001
+672,156
+57% +$257M 6.24% 5
2021
Q1 		$421M Buy
+1,171,845
New +$377M 3.96% 15

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's ELV Position: Q2 2026 in Review

Ruane, Cunniff & Goldfarb reduced its Elevance Health (ELV) stake by 29% in Q2 2026, selling an estimated $151M and leaving 979,598 shares worth $379M. The position accounts for 5.89% of the portfolio, ranked #6.

Ruane, Cunniff & Goldfarb first reported a position in ELV in Q1 2021 and has held it in 22 quarters since. The position peaked at $863M in Q1 2022. 1,604 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Ruane, Cunniff & Goldfarb held 979,598 shares of Elevance Health worth $379M as of Q2 2026.
  • Ruane, Cunniff & Goldfarb sold 408,370 Elevance Health shares in Q2 2026, an estimated $151M.
  • Elevance Health made up 5.89% of Ruane, Cunniff & Goldfarb's portfolio in Q2 2026, its #6 holding.
  • Ruane, Cunniff & Goldfarb first reported a position in Elevance Health in Q1 2021 and has held it in 22 quarters since.
  • Ruane, Cunniff & Goldfarb's Elevance Health position peaked at $863M in Q1 2022.
  • 1,604 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q2 2026, filed 14 Aug 2026.